INSUBCONTINENT EXCLUSIVE:
The Department of Disease Control (DDC) has relocated to eliminate concerns about the effectiveness and security of both monovalent and
bivalent mRNA vaccines for Covid-19, after reports of unfavorable side-effects made the rounds on social networks.
